MIM
SEM

Macroview Investment Management’s Select Medical SEM Stock Holding History

Macroview Investment Management’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-41
Closed -$768 – 455
2024
Q3 		$768 Hold
41
– – ﹤0.01% 520
2024
Q2 		$772 Hold
41
– – ﹤0.01% 520
2024
Q1 		$664 Hold
41
– – ﹤0.01% 581
2023
Q4 		$517 Hold
41
– – ﹤0.01% 575
2023
Q3 		$556 Buy
+41
New +$633 ﹤0.01% 715

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Macroview Investment Management's SEM Position: Q4 2024 in Review

Macroview Investment Management sold out of Select Medical (SEM) in Q4 2024, closing a stake of 41 shares — an estimated $768 sold.

Macroview Investment Management first reported a position in SEM in Q3 2023 and held it in 5 quarters. The position peaked at $772 in Q2 2024. 271 funds tracked by Wall St. Rank hold SEM as of Q4 2024.

  • Macroview Investment Management reported no remaining Select Medical position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 41 Select Medical shares in Q4 2024, an estimated $768.
  • Macroview Investment Management first reported a position in Select Medical in Q3 2023 and held it in 5 quarters.
  • Macroview Investment Management's Select Medical position peaked at $772 in Q2 2024.
  • 271 funds tracked by Wall St. Rank held Select Medical as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.